Skip to search formSkip to main contentSkip to account menu

fluticasone / salmeterol

Known as: fluticasone-salmeterol, FLUTICASONE/SALMETEROL, Fluticasone Salmeterol Combination 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
BACKGROUND Smoking induces airway inflammation and relative resistance to inhaled steroids. The objective of this study was to… 
2010
2010
To cite this article: van den Berge M, Luijk B, Bareille P, Dallow N, Postma DS, Lammers J‐WJ. Prolonged protection of the new… 
2010
2010
BACKGROUND The effect of the long acting beta(2)-agonist/corticosteroid combination salmeterol-fluticasone propionate (SFC) on… 
2005
2005
ABSTRACT Background: Airway inflammation and symptoms often persist in asthma patients despite treatment with inhaled… 
2001
2001
Inflammation is a critical component of asthma. Drugs that control asthma generally reduce the degree of airway inflammation… 
Review
2001
Review
2001
A 25‐year‐old woman presented in October 1999 with fever, nausea, vomiting, and a nodular eruption that had developed over the… 
2000
2000
According to a recent hypothesis, airway smooth muscle regulates airway calibre mostly at high lung volume, whereas the mucosa… 
Highly Cited
1997
Highly Cited
1997
We examined the effect of salmeterol, a long-acting beta2-adrenergic receptor agonist, on ovalbumin-induced plasma leakage and…